In vivo studies in nude mouse models have also shown that LRRC8A downregulation suppressed the proliferation of colon carcinoma, hepatocellular carcinoma, and cervical cancer (Zhang et al., 2018; Lu et al., 2019; Chen et al., 2023). Here, LRRC8A is linked to colon carcinoma.